Health
Regeneron suspends COVID-19 antibody trial among sickest patients – Gulf News
Move follows recommendation from independent committee which assesses results
A Regeneron Pharmaceuticals scientist works in the company’s Infectious disease lab in New York state on an experimental coronavirus antibody drug.
Image Credit: Regeneron / via AP file
Washington: US biotech firm Regeneron on Friday said it was suspending enrollment for a study of its COVID-19 antibody treatment among the sickest patients who require high-flow oxygen or are on ventilators.
The move follows a recommendation from an independent data monitoring committee (IDMC) which assesses the…
-
Noosa News23 hours agoDog daycare program a TikTok hit for helping disabled find work, friends
-
Noosa News23 hours agoAdvocates highlight sexual violence against older people, with Queensland elder abuse inquiry underway
-
Business22 hours ago3 steps to take to build a $1,000 monthly passive income
-
Noosa News24 hours agoOats free of gluten contaminants can’t be labelled gluten-free